Pharmafile Logo
Pharmafocus logo
Advanced Search

Philippines

Showing 11 posts of 11 posts found.

Philippines Department of Justice recommends charges against six Sanofi officials

March 1, 2019
Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines

The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …

News

Philippines’ FDA halts sales of Sanofi’s dengue vaccine

February 19, 2019
Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug …

News
dengvaxia

Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster

March 7, 2018
Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma

Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …

News

Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages

February 5, 2018
Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …

News
dengvaxia

Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi

January 30, 2018
Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Boehringer, CAR T, CAR-T, Celgene, Kymriah, Merck KGaA, Novartis, Philippines, Sanofi, gilotrif, juno therapeutics, nestle, top ten

It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …

News
philippines-1195394_960_720

Sanofi agrees to reimburse Philippines’ Dengvaxia stockpiles

January 15, 2018
Sales and Marketing Philippines, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has agreed with the Department of Health (DoH) for the Philippines to reimburse $27.86 million worth of vaccines, though …

News
spmsdsite

Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds

January 5, 2018
Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …

News
dengue_mosquito_web

Philippine FDA orders Sanofi to pull dengue vaccine ads

January 5, 2017
Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus

Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …

News
sanofi_pasteur_vaccines

Sanofi’s dengue vaccine rolled out for world’s first public immunisation program

April 4, 2016
Sales and Marketing Philippines, Sanofi, Vaccine, children, dengue, dengvaxia, immunisation, prevention, public health

Sanofi, along with its vaccines global business unit Sanofi Pasteur, has announced the beginning of the first public dengue immunisation …

News

Philippines pricing controls: Pfizer ‘considered taking drugs off the market’

September 2, 2011
Sales and Marketing Drug pricing, Philippines, price cuts

Pfizer considered withdrawing some of its products from the Philippines rather than face planned pricing controls, according to a US …

News

Latest content

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023